b. Improving quality of the vaccines, cold chain logistics safe injection
Goals Activities Target
2010 2011
2012 2013
2014 1.
Availability of Norms, Standards, Procedures and
Criteria NSPK for routine and supplementary
immunization activities SIAs
• Development and refinement of the NSPK
to correspond and updated with VPD
epidemiology • Development and
refinement of the NSPK to correspond and
updated with VPD epidemiology
• Development and refinement of the NSPK
to correspond and updated with VPD
epidemiology • Development and
refinement of the NSPK to correspond and
updated with VPD epidemiology
• Development and refinement of the NSPK
to correspond and updated with VPD
epidemiology
2. Improving quality of the
vaccines and safe injection • Using the domestic
vaccines production with Standard
Manufacture and certificate of release
from the Food and Drug Control Agency or
BPOM
• Ensuring the quality of vaccines, all distribution
for all level must use VAR form.
• Ensuring good estimation of vaccine
needed by increasing managerial capacity
through supportive supervision in all
provinces • Using the domestic
vaccines production with Standard
Manufacture and certificate of release
from the Food and Drug Control Agency or
BPOM
• Ensuring the quality of vaccines, all distribution
for all level must use VAR form.
• Ensuring good estimation of vaccine
needed by increasing managerial capacity
through supportive supervision in all
provinces • Using the domestic
vaccines production with Standard
Manufacture and certificate of release
from the Food and Drug Control Agency or
BPOM
• Ensuring the quality of vaccines, all distribution
for all level must use VAR form.
• Ensuring good estimation of vaccine
needed by increasing managerial capacity
through supportive supervision in all
provinces • Using the domestic
vaccines production with Standard
Manufacture and certificate of release
from the Food and Drug Control Agency or
BPOM
• Ensuring the quality of vaccines, all distribution
for all level must use VAR form.
• Ensuring good estimation of vaccine
needed by increasing managerial capacity
through supportive supervision in all
provinces • Using the domestic
vaccines production with Standard Manufacture
and certificate of release from the Food and Drug
Control Agency or BPOM
• Ensuring the quality of vaccines, all distribution
for all level must use VAR form.
• Ensuring good estimation of vaccine needed by
increasing managerial capacity through
supportive supervision in all provinces
3. Ensuring the
implementation of safe injection and waste
disposal • All immunization
injection are using 100 ADS
• All distributed vaccines are using 100 ADS
• Establishing the national policies on sharp waste
disposal by the National Committee on
Waste Disposal • All distributed vaccines
are using 100 ADS • 50 of districts
municipalities implementapply the
standard for waste disposal management
• All distributed vaccines are using 100 ADS
• 75 of districts municipalities
implementapply the standard for waste
disposal management • All distributed vaccines
are using 100 ADS • 100 of districts
municipalities implementapply the
standard for waste disposal management
4. Maintaining routine
reporting on cold chain inventory by level,
replacing new equipment and spare part etc. to
ensure 90 cold chain well functioning
• 85 of all cold chain equipment in each level
are well functioning • Review
cold chain
availability and national cold chain inventory
• 90 of all cold chain equipmentint each level
are well functioning • Proviancila cold chain
officers are trained in accredited cold chain
training • 95 of all cold chain
equipment in each level are well functioning
• 100 of all cold chain equipmentin each level
are well functioning • District old chain
officers are trained in accredited cold chain
training • Review cold chain
availability and national cold chain inventory
• 100 of all cold chain equipment in each level
are well functioning • All cold chain officers are
trained in accredited cold chain training
5. Planning of vaccine needs
for global epidemic preparedness
• Working closely with the Technical Working
Group TAG on Immunization, vaccine
producer PT BioFarma, NIHRD Research and
Development, in developing the plan and
introduction of seasonal influenza vaccine, H1N1,
H5N1, etc. • Working closely with
the Technical Working Group TAG on
Immunization, vaccine producer PT BioFarma,
NIHRD Research and Development, in
developing the plan and introduction of seasonal
influenza vaccine, H1N1, H5N1, etc.
• Working closely with the Technical Working
Group TAG on Immunization, vaccine
producer PT BioFarma, NIHRD Research and
Development, in developing the plan and
introduction of seasonal influenza vaccine, H1N1,
H5N1, etc. • Working closely with
the Technical Working Group TAG on
Immunization, vaccine producer PT BioFarma,
NIHRD Research and Development, in
developing the plan and introduction of seasonal
influenza vaccine, H1N1, H5N1, etc.
• Working closely with the Technical Working
Group TAG on Immunization, vaccine
producer PT BioFarma, NIHRD Research and
Development, in developing the plan and
introduction of seasonal influenza vaccine, H1N1,
H5N1, etc.
6. Empowering EPI Officers’
• Penyusunan Bahan
Ajar •
Pelatihan TOT EVSM dan DQS
• Training for DQS and Immunization EVSM
Officer at national and province level
• Training for DQS and Immunization EVSM
Officer at districts in middle regional
province • Training for DQS and
Immunization EVSM Officer at districts in
estern regional province
• Training for DQS and Immunization EVSM
Officer at districts in western regional
province
c. Strengthening monitoring, evaluation and surveillance systems